Skip to main content

Published locations for SGLT2 inhibitors, GLP-1 RAs are effective, but costly in T2D

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. SGLT2 inhibitors, GLP-1 RAs are effective, but costly in T2D

User login

  • Reset your password
  • /content/sglt2-inhibitors-glp-1-ras-are-effective-costly-t2d
  • /fedprac/article/204378/diabetes/sglt2-inhibitors-glp-1-ras-are-effective-costly-t2d
  • /internalmedicine/article/204378/diabetes/sglt2-inhibitors-glp-1-ras-are-effective-costly-t2d
  • /familymedicine/article/204378/diabetes/sglt2-inhibitors-glp-1-ras-are-effective-costly-t2d
  • /type-2-diabetes-icymi/article/204378/diabetes/sglt2-inhibitors-glp-1-ras-are-effective-costly-t2d